The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $9,284.40 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of Xolair 150 mg/mL syringes and has a completion date of December 11, 2024. DMS Pharmaceutical Group Inc. holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue delivery orders for a comprehensive range of pharmaceutical products to support the medical supply needs of military healthcare facilities. This contract is not associated with any set-aside designation, allowing DMS Pharmaceutical Group Inc. to leverage its woman-owned small business status to secure direct federal awards across multiple product categories and medical domains.
Generated 2/18/25, 1:45 PM